These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 23110009)
1. Cyclooxygenase-2 expression and its prognostic significance in clear cell renal cell carcinoma. Lee JW; Park JH; Suh JH; Nam KH; Choe JY; Jung HY; Chae JY; Moon KC Korean J Pathol; 2012 Jun; 46(3):237-45. PubMed ID: 23110009 [TBL] [Abstract][Full Text] [Related]
2. Identification and validation of novel prognostic markers in Renal Cell Carcinoma. Rabjerg M Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma. Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774 [TBL] [Abstract][Full Text] [Related]
5. High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma. Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J PLoS One; 2016; 11(11):e0166231. PubMed ID: 27861513 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of interleukin-8 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma. An H; Zhu Y; Xie H; Liu Y; Liu W; Fu Q; Ye D; Xu J Tumour Biol; 2016 Apr; 37(4):4523-9. PubMed ID: 26503211 [TBL] [Abstract][Full Text] [Related]
7. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma. Laba P; Wang J; Zhang J BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799 [TBL] [Abstract][Full Text] [Related]
8. High expression of APRIL correlates with poor prognosis in clear cell renal cell carcinoma. Lee C; Park JW; Suh JH; Moon KC Pathol Res Pract; 2015 Nov; 211(11):824-8. PubMed ID: 26296917 [TBL] [Abstract][Full Text] [Related]
9. VEGFR-1 Expression Relates to Fuhrman Nuclear Grade of Clear Cell Renal Cell Carcinoma. Lkhagvadorj S; Oh SS; Lee MR; Jung JH; Chung HC; Cha SK; Eom M J Lifestyle Med; 2014 Mar; 4(1):64-70. PubMed ID: 26064856 [TBL] [Abstract][Full Text] [Related]
10. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma. Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274 [TBL] [Abstract][Full Text] [Related]
11. Delta-like ligand 4: A predictor of poor prognosis in clear cell renal cell carcinoma. Wang W; Yu Y; Wang Y; Li X; Bao J; Wu G; Chang H; Shi T; Yue Z Oncol Lett; 2014 Dec; 8(6):2627-2633. PubMed ID: 25364440 [TBL] [Abstract][Full Text] [Related]
12. Decreased ARID1A expression correlates with poor prognosis of clear cell renal cell carcinoma. Park JH; Lee C; Suh JH; Chae JY; Kim HW; Moon KC Hum Pathol; 2015 Mar; 46(3):454-60. PubMed ID: 25628030 [TBL] [Abstract][Full Text] [Related]
13. Low NR3C2 levels correlate with aggressive features and poor prognosis in non-distant metastatic clear-cell renal cell carcinoma. Zhao Z; Zhang M; Duan X; Deng T; Qiu H; Zeng G J Cell Physiol; 2018 Oct; 233(10):6825-6838. PubMed ID: 29693713 [TBL] [Abstract][Full Text] [Related]
14. Implication of PHF2 Expression in Clear Cell Renal Cell Carcinoma. Lee C; Kim B; Song B; Moon KC J Pathol Transl Med; 2017 Jul; 51(4):359-364. PubMed ID: 28607325 [TBL] [Abstract][Full Text] [Related]
15. Low Expression of Mucin-4 Predicts Poor Prognosis in Patients With Clear-Cell Renal Cell Carcinoma. Fu H; Liu Y; Xu L; Chang Y; Zhou L; Zhang W; Yang Y; Xu J Medicine (Baltimore); 2016 Apr; 95(17):e3225. PubMed ID: 27124015 [TBL] [Abstract][Full Text] [Related]
16. High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma. Zhu ZP; Lin LR; Lv TD; Xu CR; Cai TY; Lin J Oncol Rep; 2020 Nov; 44(5):2056-2066. PubMed ID: 33000227 [TBL] [Abstract][Full Text] [Related]
17. miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer. Liu S; Wang Y; Li W; Yu S; Wen Z; Chen Z; Lin F Biomed Pharmacother; 2019 Nov; 119():109406. PubMed ID: 31514066 [TBL] [Abstract][Full Text] [Related]
18. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ; BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519 [TBL] [Abstract][Full Text] [Related]
19. Elevated tumor-to-liver standardized uptake value ratio (TLR) from preoperative Wu C; Cui Y; Zhao Y; Chen X; Liao X; Di L; Yin L; Liu M; Wang R Eur J Radiol; 2020 Oct; 131():109218. PubMed ID: 32882538 [TBL] [Abstract][Full Text] [Related]
20. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway. Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]